Segall Bryant & Hamill LLC Acquires Shares of 358,935 Bath & Body Works, Inc. (NYSE:BBWI)

Segall Bryant & Hamill LLC bought a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 358,935 shares of the company's stock, valued at approximately $10,883,000. Segall Bryant & Hamill LLC owned about 0.17% of Bath & Body Works at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in BBWI. Golden State Wealth Management LLC grew its position in shares of Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after acquiring an additional 642 shares during the last quarter. UMB Bank n.a. grew its position in shares of Bath & Body Works by 65.9% during the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after acquiring an additional 596 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in shares of Bath & Body Works by 109.7% during the fourth quarter. EverSource Wealth Advisors LLC now owns 1,629 shares of the company's stock worth $63,000 after acquiring an additional 852 shares during the last quarter. Ancora Advisors LLC bought a new position in shares of Bath & Body Works during the fourth quarter worth about $67,000. Finally, TD Private Client Wealth LLC grew its position in shares of Bath & Body Works by 34.9% during the fourth quarter. TD Private Client Wealth LLC now owns 2,290 shares of the company's stock worth $89,000 after acquiring an additional 593 shares during the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI traded up $0.08 during trading hours on Friday, hitting $31.79. 4,055,565 shares of the company's stock traded hands, compared to its average volume of 5,249,269. Bath & Body Works, Inc. has a 52 week low of $24.94 and a 52 week high of $41.87. The company's fifty day simple moving average is $30.15 and its two-hundred day simple moving average is $32.35. The company has a market cap of $6.73 billion, a price-to-earnings ratio of 8.48, a price-to-earnings-growth ratio of 1.03 and a beta of 1.72.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The company reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The company had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same period in the prior year, the firm earned $0.38 earnings per share. The business's quarterly revenue was up 2.9% on a year-over-year basis. On average, analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date was Friday, June 6th. Bath & Body Works's dividend payout ratio is presently 21.33%.

Analysts Set New Price Targets

Several research firms have recently commented on BBWI. Telsey Advisory Group restated an "outperform" rating and set a $38.00 price target (down previously from $43.00) on shares of Bath & Body Works in a research report on Thursday, May 29th. JPMorgan Chase & Co. increased their target price on shares of Bath & Body Works from $41.00 to $43.00 and gave the company an "overweight" rating in a research report on Monday, May 19th. The Goldman Sachs Group decreased their target price on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research report on Friday, May 30th. Raymond James Financial decreased their target price on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a research report on Thursday, April 17th. Finally, Citigroup increased their target price on shares of Bath & Body Works from $36.00 to $42.00 and gave the company a "buy" rating in a research report on Tuesday, May 20th. Four equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Bath & Body Works presently has a consensus rating of "Moderate Buy" and an average price target of $42.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.